Literature DB >> 24406308

Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.

Prasad S Kulkarni1, Sharad Agarkhedkar2, Sanjay Lalwani3, Ashish R Bavdekar4, Sameer Jog5, Sidram K Raut6, Varsha Parulekar7, Shalaka S Agarkhedkar2, Sonali Palkar3, Somnath Mangrule1.   

Abstract

A live attenuated influenza A(H1N1)pdm 2009 vaccine was developed and distributed in India in 2010. We estimated the vaccine effectiveness (VE) against laboratory-confirmed pandemic H1N1 (pH1N1) infections in patients with influenza-like illness who visited five tertiary care hospitals in Pune, India during June-December 2010. Swab specimens were analyzed for influenza pH1N1 by reverse transcriptase polymerase chain reaction (RT-PCR). VE was estimated using the test-negative case-control study design and logistic regression. A total of 784 patients (253 cases, 531 controls) were analyzed. The unadjusted overall VE was 75.5% (95% confidence interval [CI] 42.1-89.7), while the adjusted VE was 76% (95% CI 42.1-89.7). We conclude that the live attenuated influenza A(H1N1)pdm 2009 vaccine was effective in our study population, which has opened prospects for using this platform for trivalent formulations.

Entities:  

Keywords:  case control; effectiveness; influenza A(H1N1)pdm 2009; live attenuated vaccine; pandemic

Mesh：

Substances：

Year:  2014        PMID： 24406308      PMCID： PMC4130283          DOI： 10.4161/hv.27490

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  19 in total

1.  Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.

Authors:  Joan Puig-Barberà; Alberto Arnedo-Pena; Francisco Pardo-Serrano; María Dolores Tirado-Balaguer; Silvia Pérez-Vilar; Ester Silvestre-Silvestre; Consuelo Calvo-Mas; Lourdes Safont-Adsuara; Montserrat Ruiz-García
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

2.  Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

Authors:  Joon Young Song; Hee Jin Cheong; Jung Yeon Heo; Ji Yun Noh; Won Suk Choi; Dae Won Park; Jacob Lee; Hye Won Jeong; Sae Yoon Kee; Woo Joo Kim
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

3.  Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

Authors:  P Hardelid; D M Fleming; J McMenamin; N Andrews; C Robertson; P SebastianPillai; J Ellis; W Carman; T Wreghitt; J M Watson; R G Pebody
Journal:  Euro Surveill       Date:  2011-01-13

4.  Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.

Authors:  Jiang Wu; Fujie Xu; Li Lu; Min Lu; Liang Miao; Ting Gao; Wenyan Ji; Luodan Suo; Donglei Liu; Rui Ma; Rui Yu; Jiazi Zhangzhu; Weixiang Liu; Yang Zeng; Xiaomei Li; Xuechun Zhang; Xinghuo Pang; Ying Deng
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

5.  Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-08       Impact factor: 17.586

6.  Pandemic influenza (H1N1) 2009 is associated with severe disease in India.

Authors:  Akhilesh C Mishra; Mandeep S Chadha; Manohar L Choudhary; Varsha A Potdar
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

7.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

8.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Authors:  Edward A Belongia; Burney A Kieke; James G Donahue; Robert T Greenlee; Amanda Balish; Angie Foust; Stephen Lindstrom; David K Shay
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

9.  Estimating influenza vaccine effectiveness using routinely collected laboratory data.

Authors:  D M Fleming; N J Andrews; J S Ellis; A Bermingham; P Sebastianpillai; A J Elliot; E Miller; M Zambon
Journal:  J Epidemiol Community Health       Date:  2009-11-12       Impact factor: 3.710

10.  Protective effect of single-dose adjuvanted pandemic influenza vaccine in children.

Authors:  P G Van Buynder; J K Dhaliwal; J L Van Buynder; C Couturier; M Minville-Leblanc; R Garceau; F-W Tremblay
Journal:  Influenza Other Respir Viruses       Date:  2010-07       Impact factor: 4.380
View more
  9 in total

1.  H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

Authors:  Irina Isakova-Sivak; Marina Stukova; Mariana Erofeeva; Anatoly Naykhin; Svetlana Donina; Galina Petukhova; Victoria Kuznetsova; Irina Kiseleva; Tatiana Smolonogina; Irina Dubrovina; Maria Pisareva; Alexandra Nikiforova; Maureen Power; Jorge Flores; Larisa Rudenko
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 3.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

4.  Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study.

Authors:  Prashant V Nigwekar; Anuj Kumar; Vikram V Padbidri; Amlan Choudhury; Amol B Chaudhari; Prasad S Kulkarni
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.228

5.  Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.

Authors:  John C Victor; Kristen D C Lewis; Aldiouma Diallo; Mbayame N Niang; Bou Diarra; Ndongo Dia; Justin R Ortiz; Marc-Alain Widdowson; Jodi Feser; Rebecca Hoagland; Shannon L Emery; Kathryn E Lafond; Kathleen M Neuzil
Journal:  Lancet Glob Health       Date:  2016-10-13       Impact factor: 26.763

6.  Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine.

Authors:  Victoria Matyushenko; Irina Isakova-Sivak; Tatiana Smolonogina; Irina Dubrovina; Tatiana Tretiak; Larisa Rudenko
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

Authors:  Larisa Rudenko; Leena Yeolekar; Irina Kiseleva; Irina Isakova-Sivak
Journal:  Vaccine       Date:  2016-09-01       Impact factor: 3.641

8.  Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.

Authors:  Kristen D C Lewis; Justin R Ortiz; Mohammed Z Rahman; Min Z Levine; Larisa Rudenko; Peter F Wright; Jacqueline M Katz; Len Dally; Mustafizur Rahman; Irina Isakova-Sivak; Natalia A Ilyushina; Victoria Matyushenko; Alicia M Fry; Stephen E Lindstrom; Joseph S Bresee; W Abdullah Brooks; Kathleen M Neuzil
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

Review 9.  Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review.

Authors:  Yashwant Kumar Ratre; Naveen Kumar Vishvakarma; L V K S Bhaskar; Henu Kumar Verma
Journal:  Curr Microbiol       Date:  2020-09-21       Impact factor: 2.343
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.